Whole PRUNE2 gene sequencing on larger and different series of PC patients is needed to confirm PRUNE2 mutations as a genetic cause of malignancy of parathyroid glands and to identify a possible occurrence of mutations in other regions of the gene. This evidence concerns the gene PRUNE2 and pachyonychia congenita.